DEAL Webinar for Authors on license choice (5 Dec 2024)
Choosing the right Creative Commons (CC) licence when publishing your research is crucial. The DEAL Consortium strongly advocates for the Creative Commons license type CC BY, as emphasized in their recent campaign.
To reinforce this recommendation and to give authors a deeper insight into the licence choice and its wider implications, the organizers invited scientific authors in Germany who publish under the DEAL agreements to an exclusive webinar on 5 December 2024, 10:00h.
What you will learn:
- Why CC BY is in most cases the best choice for research publications and why other licence types such as “non-commercial” have limitations
- How to navigate the DEAL publishing workflows to select your preferred licence
- Insights into the terms and conditions of the “licence to publish” agreement based on your chosen licence
Bring your questions!
Speakers:
- Prof. Gerard Meijer: The session will be introduced by Prof. Gerard Meijer, spokesperson of the DEAL consortium, renowned researcher and one of the chief negotiators of the DEAL agreements.
- The MPDL Services gGmbH team will guide you through the publisher’s workflow.
The webinar will be held mainly in English, but questions can be asked in German.
Please register here!
